Biologics

Several clinical trials in China have been put on hold due to the coronavirus outbreak, including a treatment for a type of spondyloarthritis, according to Reuters.

This year marks the 15th anniversary of orthobiologic physician group Regenexx.

Onkos Surgical on Feb. 6 launched GenVie Magnesium Bone Scaffold, a magnesium-based bone void filler for orthopedic conditions.

Zolgensma, a gene therapy drug for spinal muscular atrophy, has been on the market since June 2019 and is widely reported to be the most expensive drug in the world.

Steven Cyr, MD, is now providing stem cell treatments at SASpine in San Antonio.

Myeliviz, a new drug to help diagnose multiple sclerosis in its earlier stages was recently approved by the FDA for human clinical trials.

Zolgensma, Novartis' gene therapy drug for spinal muscular atrophy, totaled $186 million in fourth quarter sales, according to Stat.

Here are eight things to know about the spinal fusion market.

In February, Ryan Woods, MD, will provide regenerative medicine services to patients at Orthopedics & Sports Medicine BayCare Clinic in Manitowoc, Wis., according to the Herald Times Reporter.

NanoFUSE Biologics appointed Answorth Allen, MD, Jan. 16 to its scientific advisory board, reports Benzinga.